

Fundamental dimension Equity attribute | AABVFLeader $0.010.00% Cap $1.61MP/E -5.3x QuantScore47/100 | ADIAPeer $0.110.00% Cap $10.38MP/E -0.1x QuantScore43/100 | BLGVFPeer $0.1220.00% Cap $1.68MP/E -0.1x QuantScore20/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
49/100 |
25/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 40/100 | 30/100 | 23/100 |
Growth Revenue / earnings growth & margins | 100/100 | 51/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -5.3x | -0.1x | -0.1x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -5.0x | -80.1x | -1.7x |
Price / Sales | -3.5x | 9.5x | -6.6x |
Price / Free Cash Flow | -2.3x | -62.3x | -6.6x |
PEG ratio | -0.02 | 0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 5 / 9 | 3 / 9 |
Altman Z-Score | -36.96 (Distress) | -25.43 (Distress) | -204.59 (Distress) |
Total debt / equity | -0.23 | -2.62 | -0.15 |
Quick ratio | 32.7x | 0.3x | 0.2x |
Interest coverage | -268.7x | -5.5x | -24.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +57.1% | +10879.7% | -101.3% |
Net income growth YoY | +75.7% | -118.4% | -289.6% |
Gross margin (TTM) | 103.3% | 46.7% | 122.5% |
Operating margin (FY) | 72.3% | -52.3% | 572.4% |
FCF margin (FY) | 55.1% | -25.6% | 105.2% |
5. Trailing price performancePrice change over period |
1M return | -50.0% | -9.1% | -31.8% |
3M return | -50.0% | -31.3% | -28.7% |
6M return | -66.7% | -41.8% | -57.1% |
Year to date | -43.5% | +41.0% | -46.1% |
1Y return | -52.2% | +189.5% | -65.8% |
3Y return | -49.8% | +400.0% | -32.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0471 -571.0% premium | $263.13 +239106.0% upside | $-0.9492 -878.1% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |